Catalog

Buy Singulair online without a doctor's prescription

singulair online
Singulair blocks substances in the body called leukotrienes, which are responsible for development of asthma and allergic rhinitis.
Active Ingredient: Montelukast
Availability: In Stock (27 Packages)
Singulair 10mg
Product name Per Pill Savings (only today) Per Pack
30 pills $3.36 $100.68 ADD TO CART
60 pills $2.53 $49.83 $201.35 $151.52 ADD TO CART
90 pills $2.25 $99.67 $302.03 $202.36 ADD TO CART
120 pills $2.11 $149.50 $402.70 $253.20 ADD TO CART
180 pills $1.97 $249.17 $604.05 $354.88 ADD TO CART
270 pills $1.88 $398.68 $906.09 $507.41 ADD TO CART
Singulair 5mg
Product name Per Pill Savings (only today) Per Pack
30 pills $2.37 $71.04 ADD TO CART
60 pills $1.90 $27.97 $142.09 $114.12 ADD TO CART
90 pills $1.75 $55.95 $213.14 $157.19 ADD TO CART
120 pills $1.67 $83.92 $284.18 $200.26 ADD TO CART
180 pills $1.59 $139.87 $426.27 $286.40 ADD TO CART
270 pills $1.54 $223.79 $639.40 $415.61 ADD TO CART
Singulair 4mg
Product name Per Pill Savings (only today) Per Pack
30 pills $1.39 $41.68 ADD TO CART
60 pills $1.16 $13.64 $83.36 $69.72 ADD TO CART
90 pills $1.09 $27.28 $125.04 $97.76 ADD TO CART
120 pills $1.05 $40.92 $166.72 $125.80 ADD TO CART
180 pills $1.01 $68.21 $250.09 $181.88 ADD TO CART
270 pills $0.99 $109.13 $375.13 $266.00 ADD TO CART
360 pills $0.97 $150.05 $500.17 $350.12 ADD TO CART

What is Singulair?

Singulair – leukotriene receptor blocker, anti-bronchospastic anti-inflammatory drug.

Indications for use

Chewable tablets 4 mg

  • bronchial asthma – prevention and long-term treatment in order to control the day and night symptoms of the disease in children from two years and older;
  • allergic rhinitis – relief of symptoms in children aged two years and older.

Chewable tablets 5 mg and coated tablets

  • bronchial asthma – prevention and long-term treatment of adults and children from 6 years old (for 5 mg chewable tablets) or from 15 years old (for coated tablets) in order to prevent day and night symptoms of the disease, prevent bronchospasm during physical activity, including the treatment of bronchial patients asthma with acetylsalicylic acid hypersensitivity;
  • relief of night and day symptoms of seasonal and year-round allergic rhinitis in patients over 6 years old (for 5 mg chewable tablets) or from 15 years old (for coated tablets)

Contraindications

  • age up to 2 years;
  • hypersensitivity to the components of Singulair.

Additionally for chewable tablets:

  • phenylketonuria;
  • age up to 6 years (for chewable tablets 5 mg).

Additionally for tablets, coated:

  • age up to 15 years;
  • glucose-galactose malabsorption syndrome, lactase deficiency, lactose intolerance.

The use of Singulyara during pregnancy and breastfeeding is possible only if the expected effect of therapy for the mother outweighs the potential threat to the fetus or child.

Special instructions

In case of confirmed allergy to acetylsalicylic acid and other non-steroidal anti-inflammatory drugs (NSAIDs), their simultaneous use with montelukast is contraindicated, since it is impossible to completely prevent bronchoconstriction caused by NSAIDs.

Singulair is not recommended for the treatment of acute attacks of bronchial asthma. To relieve asthma attacks, the patient should always have emergency medications with him – inhaled beta2-agonists of short duration. In the period of asthma exacerbation to stop taking the drug should not be.

In the appointment of the drug can not produce a sharp cancellation of inhaled or oral glucocorticosteroids (GCS), a gradual reduction in the dose of simultaneously applied GCS under medical supervision is allowed. A sharp decrease in the dose of systemic corticosteroids can cause rash, worsening of pulmonary symptoms, development of eosinophilia, cardiac complications and / or neuropathy, systemic eosinophilic vasculitis.

Since there is a risk of neuropsychiatric disorders during the use of Singulair, the patient should be warned about the possibility of their development and the need to immediately contact your doctor if unwanted symptoms appear.

Adult patients are advised to use caution when driving vehicles and machinery due to the risk of side effects such as dizziness and drowsiness.

How to use?

Pills are taken orally, regardless of the meal 1 time per day.

In the treatment of asthma, the drug is used in the evening, allergic rhinitis – at any time convenient for the patient. In case of bronchial asthma with concomitant allergic rhinitis, the patient takes a dose in the evening 1 time per day.

The recommended daily dosage of Singulair:

  • patients older than 15 years: 1 tablet, coated – 10 mg;
  • children aged 6 to 14 years: 1 chewable tablet – 5 mg;
  • Children from 2 to 5 years: 1 chewable tablet – 4 mg.

The therapeutic effect of the drug develops during the first day.

The patient needs to continue taking pills not only in case of exacerbation of bronchial asthma, but also in the period of achieving control over the symptoms of bronchial asthma.

In renal failure, mild and moderate severity of liver dysfunction, elderly patients do not require dose adjustment.

Side effects

Undesirable effects registered during the post-registration period of the drug use:

  • on the part of the cardiovascular system: rapid heartbeat;
  • infectious and parasitic pathologies: infections of the upper respiratory tract;
  • on the part of the blood coagulation system: bleeding tendency;
  • on the part of the psyche: anxiety, agitation (including hostility, aggressive behavior), impaired attention, disorientation, pathological dreams, insomnia, hallucinations, psychomotor activity (including anxiety, irritability, tremor), memory disorders, somnambulism, depression, suicidal thoughts and behavior;
  • on the part of the immune system: hypersensitivity reactions, including anaphylaxis; very rarely – eosinophilic infiltration of the liver;
  • on the part of the digestive system: dyspepsia, nausea, vomiting, diarrhea, pancreatitis;
  • nervous system: drowsiness, dizziness, paresthesia or hypesthesia; very rarely – seizures;
  • on the part of the respiratory system: pulmonary eosinophilia, nasal bleeding; on the part of the liver and biliary tract: an increase in the activity of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the blood; very rarely, hepatitis (including hepatocellular, cholestatic, or mixed liver damage);
  • allergic reactions: urticaria, angioedema;
  • on the part of the musculoskeletal system: myalgia, muscle cramps, arthralgia;
  • on the part of the skin and subcutaneous tissues: pruritus, rash, tendency to hematomas, erythema multiforme, erythema nodosum;
  • on the part of the urinary system: in children – enuresis;
  • general reactions: edema, asthenia (weakness) or increased fatigue, pyrexia.

Overdose

In clinical studies, long-term (22 weeks) treatment of patients with bronchial asthma with a daily dose of the drug up to 200 mg and a short (approximately 1 week) use of Singulair, with a daily dose of up to 900 mg, no overdose symptoms were identified.

In the post-registration period and in the course of clinical studies in children and adults, cases of acute overdose have been reported with a dose of at least 1000 mg of Singulair daily. Laboratory and clinical data indicate the comparability of safety profiles in children, adults and elderly patients. The most frequent side effects (psychomotor agitation, drowsiness, abdominal pain, thirst, vomiting, headache) are consistent with the safety profile of the drug.

Specific information about the treatment of overdose Singulair is missing. In acute overdose, symptomatic treatment is recommended. Data on the effectiveness of hemodialysis or peritoneal dialysis of montelukast are not available.

Save your money
Mega Discounts on Big Packs